NDC 72607-100

TAZVERIK

Tazemetostat

TAZVERIK is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Epizyme, Inc.. The primary component is Tazemetostat Hydrobromide.

Product ID72607-100_235cbcdb-e700-429c-9130-6a512a146c54
NDC72607-100
Product TypeHuman Prescription Drug
Proprietary NameTAZVERIK
Generic NameTazemetostat
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2020-01-23
Marketing CategoryNDA /
Application NumberNDA211723
Labeler NameEpizyme, Inc.
Substance NameTAZEMETOSTAT HYDROBROMIDE
Active Ingredient Strength200 mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72607-100-00

240 TABLET, FILM COATED in 1 BOTTLE (72607-100-00)
Marketing Start Date2020-01-23
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.